Catalent
Investment area
Principal Investments
Region
North America
Date of investment
December 2024
Catalent, Inc. is a leading global contract development and manufacturing organisation (CDMO) whose mission is to develop, manufacture, and supply products that help people live better and healthier lives. Catalent is dedicated to delivering unparalleled service to pharma, biotech, and consumer health customers, supporting product development, launch, and full life-cycle supply.